Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, MarketBeat reports. Five analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $79.38.

A number of brokerages have recently issued reports on HSIC. Evercore ISI boosted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Robert W. Baird reduced their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Cromwell Holdings LLC raised its stake in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares in the last quarter. Summit Securities Group LLC acquired a new position in shares of Henry Schein in the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA acquired a new position in shares of Henry Schein in the second quarter valued at approximately $37,000. Blue Trust Inc. increased its stake in shares of Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after buying an additional 475 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Trading Up 0.6 %

HSIC stock opened at $77.28 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a fifty day moving average price of $71.03 and a two-hundred day moving average price of $69.76. Henry Schein has a one year low of $63.67 and a one year high of $82.63. The stock has a market cap of $9.64 billion, a price-to-earnings ratio of 31.80, a price-to-earnings-growth ratio of 2.15 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the previous year, the business posted $1.32 earnings per share. The company’s revenue for the quarter was up .4% compared to the same quarter last year. Equities analysts anticipate that Henry Schein will post 4.78 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.